Efficacy of Topical Tofacitinib 2% Gel in Chronic Hand Eczema - A Case Series.
作者信息
Singh Bhabani S T P, Kar Bikash R, Nayak Manoj K, Nayak Tanisha
机构信息
Department of Dermatology, Venereology and Leprosy, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Department of Pathology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
出版信息
Indian Dermatol Online J. 2024 Jun 3;15(5):837-839. doi: 10.4103/idoj.idoj_589_23. eCollection 2024 Sep-Oct.
Abstract
摘要
相似文献
1
Efficacy of Topical Tofacitinib 2% Gel in Chronic Hand Eczema - A Case Series.2% 托法替布局部凝胶治疗慢性手部湿疹的疗效——病例系列
Indian Dermatol Online J. 2024 Jun 3;15(5):837-839. doi: 10.4103/idoj.idoj_589_23. eCollection 2024 Sep-Oct.
2
Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema.环孢素与外用倍他米松-17,21-二丙酸酯治疗重度慢性手部湿疹的比较。
Acta Derm Venereol. 1996 Sep;76(5):371-6. doi: 10.2340/0001555576371376.
3
Synergistic Effects of the 308-nm Excimer Light and Topical Calcipotriol for the Treatment of Chronic Hand Eczema: A Randomized Controlled Study.308nm 准分子光与卡泊三醇联合治疗手部慢性湿疹的疗效观察：一项随机对照研究
Dermatology. 2021;237(1):31-38. doi: 10.1159/000505539. Epub 2020 Jan 24.
4
Clinical efficacy of two topical corticosteroids in the management of chronic hand eczema.两种外用皮质类固醇治疗慢性手部湿疹的临床疗效
G Ital Dermatol Venereol. 2015 Jun;150(3):293-6.
5
The efficacy of a transdermal hydrogel patch containing betamethasone dipropionate for treatment of chronic hand eczema: A single-blind, randomized and controlled trial.一种含有倍他米松二丙酸酯的透皮水凝胶贴剂治疗慢性手部湿疹的疗效：一项单盲、随机对照试验。
Contact Dermatitis. 2024 Feb;90(2):153-160. doi: 10.1111/cod.14438. Epub 2023 Oct 12.
6
Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model.在小鼠特应性皮炎模型中比较外用托法替布与0.1%次氯酸
BMC Pharmacol Toxicol. 2018 Jul 3;19(1):37. doi: 10.1186/s40360-018-0232-3.
7
Beneficial Effects of Adding Topical Atorvastatin 5% Cream to Topical Betamethasone 1% Ointment on Chronic Hand Eczema.局部应用阿托伐他汀 5%乳膏联合外用倍他米松 1%软膏治疗慢性手部湿疹的疗效。
Arch Iran Med. 2020 Sep 1;23(9):605-613. doi: 10.34172/aim.2020.71.
8
Oral Tofacitinib in the Treatment of Moderate-to-Severe Chronic Hand Eczema: A Case Series.口服托法替布治疗中度至重度慢性手部湿疹：病例系列
Dermatitis. 2025 Jan-Feb;36(1):e94-e97. doi: 10.1089/derm.2024.0032. Epub 2024 Apr 17.
9
Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients.阿利特罗汀治疗慢性手部湿疹患者时是否联合使用局部皮质类固醇的疗效。
J Dermatol. 2019 Nov;46(11):998-1005. doi: 10.1111/1346-8138.15071. Epub 2019 Sep 18.
10
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.特应性皮炎的局部靶向托法替尼：一项 IIa 期随机试验。
Br J Dermatol. 2016 Nov;175(5):902-911. doi: 10.1111/bjd.14871. Epub 2016 Sep 24.
本文引用的文献
1
Current emerging and investigational drugs for the treatment of chronic hand eczema.治疗慢性手部湿疹的现有新型和研究性药物。
Expert Opin Investig Drugs. 2022 Aug;31(8):843-853. doi: 10.1080/13543784.2022.2087059. Epub 2022 Jun 17.
2
The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.在一项为期 16 周的随机 2b 期临床试验中，乳膏制剂的泛 JAK 抑制剂地洛格司亭在慢性手部湿疹中表现出剂量反应。
Br J Dermatol. 2022 Jul;187(1):42-51. doi: 10.1111/bjd.21037. Epub 2022 Apr 19.
3
Topical Janus kinase inhibitors: A review of applications in dermatology.局部 Janus 激酶抑制剂：在皮肤病学中的应用综述。
J Am Acad Dermatol. 2018 Sep;79(3):535-544. doi: 10.1016/j.jaad.2018.04.018. Epub 2018 Apr 16.
4
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.2%托法替布软膏，一种局部应用的Janus激酶抑制剂，用于斑秃治疗：一项针对10例患者的初步研究。
J Am Acad Dermatol. 2018 Feb;78(2):403-404.e1. doi: 10.1016/j.jaad.2017.10.043. Epub 2017 Nov 3.
Zotero 插件